The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems
Abstract
Prokaryotic adaptive immune systems use Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-associated (Cas) proteins for RNA-guided cleavage of foreign genetic elements. The focus of this review, Type VI CRISPR-Cas systems, contain a single protein, Cas13 (formerly C2c2) that when assembled with a CRISPR RNA (crRNA) forms a crRNA-guided RNA-targeting effector complex. Type VI CRISPR-Cas systems can be divided into four subtypes (A-D) based on Cas13 phylogeny. All Cas13 proteins studied to date possess two enzymatically distinct ribonuclease activities that are required for optimal interference. One RNase is responsible for pre-crRNA processing to form mature Type VI interference complexes, while the other RNase activity provided by the two Higher Eukaryotes and Prokaryotes Nucleotide-binding (HEPN) domains, is required for degradation of target-RNA during viral interference. In this review, I will compare and contrast what is known about the molecular architecture and behavior of Type VI (A-D) CRISPR-Cas13 interference complexes, how this allows them to carry out their RNA-targeting function, how Type VI accessory proteins are able to modulate Cas13 activity, and how together all of these features have led to the rapid development of a range of RNA-targeting applications. Throughout I will also discuss some of the outstanding questions regarding Cas13's molecular behavior, and its role in bacterial adaptive immunity and RNA-targeting applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Gootenberg, J. S., Abudayyeh, O. O., Kellner, M. J., Joung, J., Collins, J. J., & Zhang, F. (2018) · Science · doi:10.1126/science.aaq0179 · Cited by 2,638
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
Mojica, F. J. M., D�ez-Villase�or, C., Garc�a-Mart�nez, J., & Soria, E. (2005) · Journal of Molecular Evolution · doi:10.1007/s00239-004-0046-3 · Cited by 2,042
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Cox, D. B. T., Gootenberg, J. S., Abudayyeh, O. O., Franklin, B., Kellner, M. J., Joung, J., & Zhang, F. (2017) · Science · doi:10.1126/science.aaq0180 · Cited by 1,834
Bolotin, A., Quinquis, B., Sorokin, A., & Ehrlich, S. D. (2005) · Microbiology · doi:10.1099/mic.0.28048-0 · Cited by 1,558
RNA virus interference via CRISPR/Cas13a system in plants
Aman, R., Ali, Z., Butt, H., Mahas, A., Aljedaani, F., Khan, M. Z., Ding, S., & Mahfouz, M. (2018) · Genome Biology · doi:10.1186/s13059-017-1381-1 · Cited by 1,497
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
Mojica, F. J. M., Díez-Villaseñor, C., García-Martínez, J., & Almendros, C. (2009) · Microbiology · doi:10.1099/mic.0.023960-0 · Cited by 1,426
Diversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423
Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016) · Nature · doi:10.1038/nature19802 · Cited by 1,236
Self-citationStructures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Pourcel, C., Salvignol, G., & Vergnaud, G. (2005) · Microbiology · doi:10.1099/mic.0.27437-0 · Cited by 1,201
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Konermann, S., Lotfy, P., Brideau, N. J., Oki, J., Shokhirev, M. N., & Hsu, P. D. (2018) · Cell · doi:10.1016/j.cell.2018.02.033 · Cited by 1,164
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031
Diversity and evolution of class 2 CRISPR–Cas systems
Shmakov, S., Smargon, A., Scott, D., Cox, D., Pyzocha, N., Yan, W., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,029
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
Wright, A. V., Nuñez, J. K., & Doudna, J. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.035 · Cited by 989
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
Fonfara, I., Richter, H., Bratovič, M., Le Rhun, A., & Charpentier, E. (2016) · Nature · doi:10.1038/nature17945 · Cited by 988
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., & Siksnys, V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr606 · Cited by 834
Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
Yamano, T., Nishimasu, H., Zetsche, B., Hirano, H., Slaymaker, I. M., Li, Y., Fedorova, I., Nakane, T., Makarova, K. S., Koonin, E. V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.003 · Cited by 764
Unravelling the structural and mechanistic basis of CRISPR–Cas systems
van der Oost, J., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 714
Nucleases: diversity of structure, function and mechanism
Yang, W. (2011) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000181 · Cited by 692
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & van der Oost, J. (2016) · Science · doi:10.1126/science.aad5147 · Cited by 671
Self versus non-self discrimination during CRISPR RNA-directed immunity
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature · doi:10.1038/nature08703 · Cited by 637
Programmable RNA recognition and cleavage by CRISPR/Cas9
O’Connell, M. R., Oakes, B. L., Sternberg, S. H., East-Seletsky, A., Kaplan, M., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13769 · Cited by 632
Self-citationConformational control of DNA target cleavage by CRISPR–Cas9
Sternberg, S. H., LaFrance, B., Kaplan, M., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature15544 · Cited by 627
Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a
Swarts, D. C., van der Oost, J., & Jinek, M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.016 · Cited by 608
New CRISPR–Cas systems from uncultivated microbes
Burstein, D., Harrington, L. B., Strutt, S. C., Probst, A. J., Anantharaman, K., Thomas, B. C., Doudna, J. A., & Banfield, J. F. (2017) · Nature · doi:10.1038/nature21059 · Cited by 582
Smargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.023 · Cited by 575
The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a
Liu, L., Li, X., Ma, J., Li, Z., You, L., Wang, J., Wang, M., Zhang, X., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2017.06.050 · Cited by 538
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
Nelles, D. A., Fang, M. Y., O’Connell, M. R., Xu, J. L., Markmiller, S. J., Doudna, J. A., & Yeo, G. W. (2016) · Cell · doi:10.1016/j.cell.2016.02.054 · Cited by 527
Self-citationA cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
Kazlauskiene, M., Kostiuk, G., Venclovas, Č., Tamulaitis, G., & Siksnys, V. (2017) · Science · doi:10.1126/science.aao0100 · Cited by 521
Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
Niewoehner, O., Garcia-Doval, C., Rostøl, J. T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L. A., & Jinek, M. (2017) · Nature · doi:10.1038/nature23467 · Cited by 509
Makarova, K. S., Aravind, L., Wolf, Y. I., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-38 · Cited by 470
Yan, W. X., Chong, S., Zhang, H., Makarova, K. S., Koonin, E. V., Cheng, D. R., & Scott, D. A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.028 · Cited by 462
The crystal structure of Cpf1 in complex with CRISPR RNA
Dong, D., Ren, K., Qiu, X., Zheng, J., Guo, M., Guan, X., Liu, H., Li, N., Zhang, B., Yang, D., et al. (2016) · Nature · doi:10.1038/nature17944 · Cited by 430
Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity
Samai, P., Pyenson, N., Jiang, W., Goldberg, G. W., Hatoum-Aslan, A., & Marraffini, L. A. (2015) · Cell · doi:10.1016/j.cell.2015.04.027 · Cited by 426
Argonaute Divides Its RNA Guide into Domains with Distinct Functions and RNA-Binding Properties
Wee, L. M., Flores-Jasso, C. F., Salomon, W. E., & Zamore, P. D. (2012) · Cell · doi:10.1016/j.cell.2012.10.036 · Cited by 389
Lee, K. P. K., Dey, M., Neculai, D., Cao, C., Dever, T. E., & Sicheri, F. (2008) · Cell · doi:10.1016/j.cell.2007.10.057 · Cited by 379
Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities
Liu, L., Li, X., Wang, J., Wang, M., Chen, P., Yin, M., Li, J., Sheng, G., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2016.12.031 · Cited by 328
RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes
East-Seletsky, A., O’Connell, M. R., Burstein, D., Knott, G. J., & Doudna, J. A. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.008 · Cited by 296
Self-citationHale, C. R., Majumdar, S., Elmore, J., Pfister, N., Compton, M., Olson, S., Resch, A. M., Glover, C. V. C., Graveley, B. R., Terns, R. M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.023 · Cited by 294
Structure and Mechanism of the CMR Complex for CRISPR-Mediated Antiviral Immunity
Zhang, J., Rouillon, C., Kerou, M., Reeks, J., Brugger, K., Graham, S., Reimann, J., Cannone, G., Liu, H., Albers, S.-V., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.013 · Cited by 292
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 282
Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d
Zhang, C., Konermann, S., Brideau, N. J., Lotfy, P., Wu, X., Novick, S. J., Strutzenberg, T., Griffin, P. R., Hsu, P. D., & Lyumkis, D. (2018) · Cell · doi:10.1016/j.cell.2018.09.001 · Cited by 276
Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A. O., Dickman, M. J., Horvath, P., & Siksnys, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.027 · Cited by 275
Salomon, W. E., Jolly, S. M., Moore, M. J., Zamore, P. D., & Serebrov, V. (2015) · Cell · doi:10.1016/j.cell.2015.06.029 · Cited by 270
Anantharaman, V., Makarova, K. S., Burroughs, A. M., Koonin, E. V., & Aravind, L. (2013) · Biology Direct · doi:10.1186/1745-6150-8-15 · Cited by 262
Adaptation in CRISPR-Cas Systems
Sternberg, S. H., Richter, H., Charpentier, E., & Qimron, U. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.030 · Cited by 253
Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9
Batra, R., Nelles, D. A., Pirie, E., Blue, S. M., Marina, R. J., Wang, H., Chaim, I. A., Thomas, J. D., Zhang, N., Nguyen, V., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.010 · Cited by 252
Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate
Schuster, C. F., & Bertram, R. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12074 · Cited by 205
RNA-based recognition and targeting: sowing the seeds of specificity
Gorski, S. A., Vogel, J., & Doudna, J. A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.174 · Cited by 190
SnapShot: Class 2 CRISPR-Cas Systems
Makarova, K. S., Zhang, F., & Koonin, E. V. (2017) · Cell · doi:10.1016/j.cell.2016.12.038 · Cited by 188
CRISPR-Cas: Evolution of an RNA-based adaptive immunity system in prokaryotes
Koonin, E. V., & Makarova, K. S. (2013) · RNA Biology · doi:10.4161/rna.24022 · Cited by 186
RNA-dependent RNA targeting by CRISPR-Cas9
Strutt, S. C., Torrez, R. M., Kaya, E., Negrete, O. A., & Doudna, J. A. (2018) · eLife · doi:10.7554/elife.32724 · Cited by 186
CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems
Makarova, K. S., Anantharaman, V., Grishin, N. V., Koonin, E. V., & Aravind, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00102 · Cited by 183
Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response
Han, Y., Donovan, J., Rath, S., Whitney, G., Chitrakar, A., & Korennykh, A. (2014) · Science · doi:10.1126/science.1249845 · Cited by 178
Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme
Knott, G. J., East-Seletsky, A., Cofsky, J. C., Holton, J. M., Charles, E., O'Connell, M. R., & Doudna, J. A. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3466 · Cited by 174
Self-citationMethods for predicting bacterial protein subcellular localization
Gardy, J. L., & Brinkman, F. S. L. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1494 · Cited by 169
Shmakov, S. A., Makarova, K. S., Wolf, Y. I., Severinov, K. V., & Koonin, E. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803440115 · Cited by 169
SnapShot: Class 1 CRISPR-Cas Systems
Makarova, K. S., Zhang, F., & Koonin, E. V. (2017) · Cell · doi:10.1016/j.cell.2017.02.018 · Cited by 167
Donovan, J., Rath, S. P., Kolet-Mandrikov, D., & Korennykh, A. V. (2017) · RNA · doi:10.1261/rna.062000.117 · Cited by 163
CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9
Dugar, G., Leenay, R. T., Eisenbart, S. K., Bischler, T., Aul, B. U., Beisel, C. L., & Sharma, C. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.032 · Cited by 156
Huang, H., Zeqiraj, E., Dong, B., Jha, B. K., Duffy, N. M., Orlicky, S. M., Thevakumaran, N., Talukdar, M., Pillon, M. C., Ceccarelli, D. F. J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.025 · Cited by 153
RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a
Tambe, A., East-Seletsky, A., Knott, G. J., Doudna, J. A., & O’Connell, M. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.105 · Cited by 153
Self-citationGenetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System
Hatoum-Aslan, A., Maniv, I., Samai, P., & Marraffini, L. A. (2013) · Journal of Bacteriology · doi:10.1128/jb.01130-13 · Cited by 151
CRISPR adaptive immune systems of Archaea
Vestergaard, G., Garrett, R. A., & Shah, S. A. (2014) · RNA Biology · doi:10.4161/rna.27990 · Cited by 145
Cutting it close: CRISPR-associated endoribonuclease structure and function
Hochstrasser, M. L., & Doudna, J. A. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.10.007 · Cited by 140
Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6
Niewoehner, O., & Jínek, M. (2016) · RNA · doi:10.1261/rna.054098.115 · Cited by 127
Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complexPreprint
Hale, C. R., Cocozaki, A. I., Li, H., Terns, R. M., & Terns, M. P. (2014) · Genes & Development · doi:10.1101/gad.250712.114 · Cited by 114
First indication for a functional CRISPR/Cas system in Francisella tularensis
Schunder, E., Rydzewski, K., Grunow, R., & Heuner, K. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2012.11.004 · Cited by 112
Adaptation and modification of three CRISPR loci in two closely related cyanobacteria
Hein, S., Scholz, I., Voß, B., & Hess, W. R. (2013) · RNA Biology · doi:10.4161/rna.24160 · Cited by 102
Coupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices
Koonin, E. V., & Zhang, F. (2016) · BioEssays · doi:10.1002/bies.201600186 · Cited by 102
Pathogen detection in the CRISPR–Cas era
Sashital, D. G. (2018) · Genome Medicine · doi:10.1186/s13073-018-0543-4 · Cited by 101
Rousseau, B. A., Hou, Z., Gramelspacher, M. J., & Zhang, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.025 · Cited by 92
The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease
Sheppard, N. F., Glover, C. V. C., Terns, R. M., & Terns, M. P. (2015) · RNA · doi:10.1261/rna.039842.113 · Cited by 76
Ribonuclease L and metal-ion–independent endoribonuclease cleavage sites in host and viral RNAs
Cooper, D. A., Jha, B. K., Silverman, R. H., Hesselberth, J. R., & Barton, D. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku118 · Cited by 73
The prospects for designer single-stranded RNA-binding proteins
Mackay, J. P., Font, J. S., & Segal, D. J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2005 · Cited by 70
Rath, S. P., Donovan, J., Whitney, G., Chitrakar, A., Wang, W., & Korennykh, A. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513034112 · Cited by 52
Conformational regulation of CRISPR-associated nucleases
Jackson, R. N., van Erp, P. B. G., Sternberg, S. H., & Wiedenheft, B. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.010 · Cited by 48
Programmable RNA recognition using a CRISPR-associated Argonaute
Lapinaitė, A., Doudna, J. A., & Cate, J. H. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717725115 · Cited by 47
Das, K., Acton, T., Chiang, Y., Shih, L., Arnold, E., & Montelione, G. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400189101 · Cited by 42
Kim, Y. K., Kim, Y., & Oh, B. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24183 · Cited by 36
Han, W., Pan, S., Mendez, B. L., Montoya, G., & She, Q. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx726 · Cited by 36
Maier, L., Stachler, A.-E., Saunders, S. J., Backofen, R., & Marchfelder, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617506 · Cited by 32
Targeting cellular mRNAs translation by CRISPR-Cas9
Liu, Y., Chen, Z., He, A., Zhan, Y., Li, J., Liu, L., Wu, H., Zhuang, C., Lin, J., Zhang, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep29652 · Cited by 30
Semenova, E., Kuznedelov, K. D., Datsenko, K. A., Boudry, P., Savitskaya, E. E., Medvedeva, S., Beloglazova, N. G., Logacheva, M. D., Yakunin, A. F., & Severinov, K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv546 · Cited by 26
Reversal of molecular pathology by RNA-targeting Cas9 in a myotonic dystrophy mouse modelPreprint
Batra, R., Nelles, D. A., Krach, F., Thomas, J. D., Snjader, L., Blue, S. M., Aigner, S., Swanson, M. S., & Yeo, G. W.-M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/184408 · Cited by 5
Cited by
Diagnosing COVID-19: The Disease and Tools for Detection
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020) · ACS Nano · doi:10.1021/acsnano.0c02624 · Cited by 1,754
Xu, Y., & Li, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.031 · Cited by 404
Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes
Xu, C., Zhou, Y., Xiao, Q., He, B., Geng, G., Wang, Z., Cao, B., Dong, X., Bai, W., Wang, Y., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01124-4 · Cited by 351
Manghwar, H., Li, B., Ding, X., Hussain, A., Lindsey, K., Zhang, X., & Jin, S. (2020) · Advanced Science · doi:10.1002/advs.201902312 · Cited by 347
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
Atzrodt, C. L., Maknojia, I., McCarthy, R. D. P., Oldfield, T. M., Po, J., Ta, K. T. L., Stepp, H. E., & Clements, T. P. (2020) · The FEBS Journal · doi:10.1111/febs.15375 · Cited by 341
Metadata
- Authors
- O'Connell, M. R.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 431
- Issue
- 1
- Pages
- 66-87
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2809070871
- Cited by
- 346
- References
- 102
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.